Current News and Announcements
Faculty Recruitment - Assistant/Associate Professor
2009 Avanti Award in Lipids
The Biophysical Society has selected Professor Stephen H. White as the recipient of the 2009 Avanti Award in Lipids for his novel findings in the areas of membrane structure and protein insertion into membranes. The honor will be presented to Dr. White at the 2009 Annual Meeting in Boston.
Albert Zlotnik joins Physiology & Biophysics!
We welcome
our newest faculty member, Dr. Albert Zlotnik, to the Department of Physiology &
Biophysics. Dr. Zlotnik is appointed as a member of our Department and in
conjunction with the
PRIME-LC program. Dr. Zlotnik is an internationally recognized
immunologist/molecular biologist with over twenty years experience in both
academic science and biotechnology. He has extensive experience in chemokine
biology and cancer, and is a highly innovative scientist experienced in the
molecular characterization of human diseases using genomic-microarray
technologies. Dr. Zlotnik has published more than 170 research papers and holds
numerous patents. His research output has been prolific, novel and highly cited:
Dr. Zlotnik is recognized by Thompson Scientific ISI as a “Highly Cited
Researcher”. (http://isihighlycited.com).
This means that a researcher is “among the 250 most cited researchers for their
published articles within a specific time-period”. Seven of his citations
have been referenced more than 700 times, a remarkable achievement attesting to
recognition and productivity on different research topics.
Excellence in Teaching Awards
Physiology & Biophysics Department members were given teaching awards for
2007-2008:
Excellence in Teaching: Dr. Kenneth Longmuir, Dr. K. George Chandy, and Dr. Harry Haigler
Kaiser Permanente award for Teaching-Basic Science: Dr. Harry Haigler
Vincent P. Carroll award for distinguished research: Sindy Wei - Congratulations to Sindy and everyone in the Cahalan lab!
Jay Gargus gave a talk at the Neurobiology of Autism Colloquium, as summarized in the "Autism Speaks" website
http://www.autismspeaks.org/science/scientificmeetings/neurochemistry_colloquium_report.php
Jay Gargus, M.D., Ph.D., began the special session by speaking about
mitochondrial dysfunction, opening his talk with a commentary on the Federal
Government's recent settlement of one autism case with mitochondrial
dysfunction, and MMR vaccine, and the timely nature of the meeting. Recent
studies have shown that a subset of autistic subjects is associated with
mitochondrial energy deficiency that is identified as impairment in fat and
carbohydrate metabolism. This type of mitochondrial defiency is similar, but
more subtle than those seen in classic mitochondrial defects. Mild mitochondrial
dysfunction has also been found in the subset of autistic patients with a
genetic defect on chromosome 15. Dr. Gargus also discussed rare cases of
familial autism associated with sudden infant death syndrome (SIDS) or
associated with abnormalities in cellular calcium homeostasis.
Doctorate of Philosophy honoris causa
The Faculty of Science at
Irwin A. Rose Lectureship
The Department held the 2007
Irwin A. Rose
Lectureship on December 10, 2007. The event featured a scientific presentation
by Dr. Tony
Hunter, Ph.D. who spoke on “Cell Signaling, and the Interplay between
Phosphorylation and Ubiquitination”. Over
125 guests attended the talk and reception in Dr. Rose’s honor.
2007 Physiology and
Biophysics Retreat
The Department held its research retreat at the UCLA Conference Center at
Lake Arrowhead in October. The event features scientific presentations by
faculty members and a poster session in which graduate students and postdoctoral
fellows report their latest findings. The "Outstanding Poster Award" this year
was shared by Kym Garrod (Cahalan Lab), Aubin Penna (Cahalan
Lab), and Alex Froger (Hall Lab).
More Kudos To Kym
Kym Garrod received the Achievement Rewards for College Scientists (ARCS)
Fellowship Award of $20,000 for her work in the Cahalan lab. Kym also won the
best poster award ($250) in the Immunology Fair and was selected for support
through the NIH Immunology Training Grant. Kym's "lucky poster" also helped her
at the |Department Retreat at Lake Arrowhead, where she was selected along with
Aubin Penna and Alex Froger for poster awards.
The Scientist
Discoveries from the Cahalan lab were featured recently in The
Scientist in an article called "Cracking open a new channel family".
UCI and Harvard researchers team up to produce innovative Web site
Excellence in Teaching Awards
Drs. George Chandy and Ken Longmuir received
"Excellence in Teaching" awards from the medical students for their
contributions to the 2006-2007 Medical Physiology course. In addition, Dr.
Longmuir received the "Silver Beaker", the award presented to the most
outstanding Basic Science faculty member for the 2006-2007 school year.
William D. Redfield
Memorial Fellowship
Kym Garrod was
recently awarded the William D. Redfield Memorial Fellowship with a $1000 prize
to support her research effort in the Cahalan lab. This fellowship recognizes
excellence in research accomplishment by a graduate student within a broadly
defined area of molecular biology. Kym was selected for her research project on
imaging the dynamics of natural killer cells and their role in tissue rejection,
one part of which has recently been accepted for publication by the Proceedings
of the National Academy of Sciences. Kym not only is excelling in her thesis
research, but she has also been a catalyst for scientific interactions in the
Department by initiating the Research in Progress seminar series among graduate
students and postdocs, and for organizing the ever-popular monthly barbecues. We
congratulate Kym and look for her to go on to a highly successful academic
career.
Science Magazine’s
Signaling Breakthrough of the Year (2005 and 2006)
For the past
two years, discoveries from the Cahalan lab have been recognized by Science
magazine as Signaling Breakthroughs. T lymphocytes require a rise in
intracellular Ca2+ levels to become activated. It has long been known that Ca2+
enters the cell through a particular type of channel, called CRAC for Ca2+
Release-Activated Ca2+ channel. But the molecular identity of the channel and
the mechanism of activation remained mysterious until recently. Using RNA
interference screening in collaboration with researchers at TorreyPines
Therapeutics in LaJolla, Cahalan’s group discovered
two key membrane proteins, Stim and Orai, that provide the missing link in the
signal transduction cascade from T cell receptor engagement to cell
proliferation critical for the immune response. Stim, the Signaling
Breakthrough for 2005, is a dual purpose molecule. It senses the Ca2+ content
within the lumen of the endoplasmic reticulum, using an EF-hand motif near the
N-terminus, and translocates to the plasma membrane when the Ca2+ store is
depleted. Orai, the Signaling Breakthrough for 2006, forms the Ca2+ channel
itself following interaction with Stim. The molecular requirements and
activation mechanisms of the CRAC channel have been a sort of holy grail in the
field of Ca2+ signaling. The Cahalan group has published two Nature papers, a
PNAS paper, and a Journal of Cell Biology paper within the past two years
describing these discoveries. For more information see the links to Science
Magazine:
Orai: http://stke.sciencemag.org/cgi/content/full/sigtrans;2007/367/eg1
Stim: http://stke.sciencemag.org/cgi/content/full/2006/316/eg1
Natural compounds block
autoimmune response in diabetes, arthritis
UCI study identifies how treatment can limit impact of T-cells in autoimmune
diseases
Irvine, Calif., November 6, 2006
Natural compounds derived from a sea
anemone extract and a shrub plant have been found to block the autoimmune
disease response in type-1 diabetes and rheumatoid arthritis, according to
University of California, Irvine researchers.
The study shows both in human and animal tests how these compounds work to deter
the effect of autoimmune T-cells, white blood cells that attack the body. The
goal, according to UCI researchers, is to develop new treatments from these
compounds that will target these destructive T-cells while allowing other white
blood cells to fight disease and infection.
Study results appear Nov. 6-10 in the Early Online Edition of the Proceedings of
the National Academy of Sciences.
The study, led by UC Irvine School of Medicine researchers George Chandy and
Christine Beeton, identifies how these compounds work against a type of white
blood cells called effector memory T lymphocytes, which play a major role in
autoimmunity. Both compounds block an ion channel in these cells that prevents
the cells from proliferating and producing chemicals called cytokines that
attack the body during autoimmune disease states.
“Autoimmune diseases affect millions of Americans, and any new therapies that
can aid them will have great significance,” Chandy said. “What’s promising about
this study is that we identified a protein target on the T-cells that promote
autoimmune activity and the compounds that can selectively block the target and
shut down the destructive cells.”
White blood cells patrol the body to
fight against cancer and infections, but if some of these cells turn against the
body they are meant to protect, they cause autoimmune diseases. Millions of
people worldwide are afflicted with disabling autoimmune disorders. Two examples
of this large class of diseases are type-1 diabetes, in which white blood cells
attack the pancreas, and rheumatoid arthritis, in which the joints are attacked.
In their study, the UCI researchers used modified compounds derived from the rue
plant (PAP-1) and a Cuban sea anemone extract (SL5), both of which block the ion
channel in the destructive T-cells.
In one set of tests using blood samples from type-1 diabetes patients and joint
fluid from people with rheumatoid arthritis, the researchers found that both
compounds suppressed the function of the autoimmune T-cells without affecting
other T-cells that fight infections.
In another set of tests using rats, the compound from the rue shrub plant
delayed the onset and reduced the incidence of disease in diabetic rats, while
the venom compound stopped the progression of the disease and improved the joint
function of rats with experimental autoimmune arthritis. In these rat tests, the
compounds were nontoxic.
The Chandy laboratory previously discovered that SL5 compound was effective in
treating rats with an experimental model of multiple sclerosis, another
devastating autoimmune disease. Preclinical safety studies on PAP-1 and SL5 are
under way in collaboration with AIRMID, a biotech company in the San Francisco
Bay Area.
“We began our work on these natural
products many years ago when we came across a report that described the
beneficial effect of a scorpion sting on a patient with multiple sclerosis,”
Beeton said. “This work also speaks to the importance of protecting our plant
and animal biodiversity – you never know where a new medicine will come from.”
Heike Wulff from University of California, Davis is a co-lead author, and other
authors from UCI, UC Davis, Johns Hopkins University, Bachem Biosciences and the
Benaroya Research Institute in Seattle are noted in the study text. The National
Institutes of Health, American Diabetes Association, Juvenile Diabetes Research
Foundation, National Multiple Sclerosis Society, Arthritis National Research
Foundation and David Israelsky provided support for this study.
About type-1 diabetes and rheumatoid arthritis: The American Diabetes
Association estimates that type-1 diabetes mellitus, also known as juvenile
diabetes, affects one in every 400 or 600 children and adolescents in the U.S.
It is characterized by a destruction of the cells that produce insulin in the
pancreas. Without enough insulin, the body cannot correctly regulate levels of
blood glucose, a major source of energy for the body. Type-1 diabetes can lead
to serious complications such as heart disease, blindness, and nerve or kidney
damage.
In rheumatoid arthritis, white blood cells induce inflammation in the joints,
leading to muscle and joint aches, stiffness, and fatigue. According to the
Arthritis Foundation, rheumatoid arthritis is one of the most serious and
disabling types, affecting mostly women. An estimated 2.1 million people in the
U.S. have rheumatoid arthritis. Some recent studies have suggested that the
overall number of new cases of rheumatoid arthritis actually may be going down.
Teaching Award
Professor K. George Chandy
was the recipient of the Excellence in Teaching Award for Physiology for
2005/2006.
Space Cycle is Out of this World!
Honor Award
Ralph Alden Bradshaw 65th
Birthday Symposium"From Proteins to Proteomics"
The symposium will feature fifteen speakers who are either former students or
close friends and collaborators of Dr. Bradshaw's. It has been organized into
four sessions including talks on protein structure, cell biology, cell
signaling, and the fibroblast growth factor family of proteins. Sir Tom Blundell
will give the opening lecture the night before.
Nancy Allbritton, Cell Detective!
Professor
Nancy Allbritton was featured “In the lab” on Friday, March 17, 2006 in the
OC Register. Dr. Allbritton’s work stretches from physiology to chemistry to
biophysics and biomedical engineering. Most of it is in the service of
understanding cells. The focus of Dr. Allbritton’s research looks at the
molecular circuitry of cells in living humans and animals. Working with others,
she designed better “micropallet arrays” for scientists who want to investigate
cells faster and more effectively. She also made it easier to gather cells that
warrant a closer look by geneticists and biochemists. According to Dr.
Allbritton, “Our understanding of how our bodies work is rapidly evolving
because we are learning how cells work at the molecular level. My research
brings together principles from chemistry, physics and engineering to study the
dynamic interplay of molecules with each cell."
Biophysical Society's 2006 New and Notable
Symposium
Professor Jim Hall was selected to give a talk in the Biophysical
Society's 2006 New and Notable Symposium at the annual meeting in Salt Lake
City. Hall s talk, Amyloid oligomers increase membrane conductance by altering
dielectric structure , will be one of four which were selected for the symposium
out of more than 150 nominated by society members and others. Although the title
does not mention Alzheimer s Disease, the talk will present a new mechanism for
the toxic effects of amyloids which are thought to be the root cause of
Alzheimer s. The work is a collaboration between three labs at UCI, Hall's,
Charles Glabe's and Mike Cahalan's and a group at NIST, the National Institute
of Standards and Technology in Gaithersburg Maryland.
WHAT A HEADACHE!!!
Professor J. Jay Gargus has been
selected to receive the "National Headache Foundation Lectureship Award" for
2006 for his work on genetic causes of migraine. Dr. Gargus discovered how
specific mutations of the sodium/potassium pump (ATP1A2) causes a rare
dominantly inherited migraine syndrome in families. Migraine has a strong
genetic component, but is most commonly a complex polygenic trait. Recently,
however, reports of rare inherited Mendelian dominant migraine with aura,
Familial Hemiplegic Migraine (FHM), have provided important insight into
migraine pathophysiology. Mutations in voltage-gated calcium and sodium
channels can also cause FHM, and now Dr. Gargus' work has shown how the sodium
pump, an enzyme transporter that sets concentration gradients for sodium and
potassium across plasma membranes, can also result in the phenotype of migraine
headache (see Segall et al J Biol Chem 279:43692-43696, 2004; Segall
et al Proc. Nat. Acad. Sci. USA 102:11106-11111, 2005). This award
is generously underwritten by an unrestricted educational grant from Merck &
Co., Inc. Dr. Gargus' lecture titled “Molecular
lesions underlying Familial Hemiplegic Migraine provide insights into migraine
pathogenesis and potential drug targets”
reflects an extended collaboration between the
Departments of Physiology & Biophysics and Pediatrics, section of Human
Genetics, at the University of California, Irvine, and the Departments of
Biochemistry and Medicine, at McGill University, Montreal, Canada and will be
presented at the National Headache Foundation’s 3rd Annual Headache
Research Summit in Palm Springs on Thursday, February 16.
Michael D. Cahalan, Ph.D.,
Recipient of the NINDS Javits Award
The National Institute of
Neurological Disorders and Stroke (NINDS), a part of the National Institutes of
Health, has named six scientists to receive its prestigious Senator Jacob Javits
Award in the Neurosciences. The award is given to individual investigators who
have demonstrated exceptional scientific excellence and productivity in research
supported by the NINDS and who are expected to conduct innovative research over
the next 7 years.
Authorized by the Congress in 1983, the award honors the late U.S. Senator Jacob K. Javits (R-NY), who was a strong advocate for research on a variety of neurological disorders. Senator Javits suffered from amyotrophic lateral sclerosis, the disabling neurodegenerative disease also known as Lou Gehrig’s disease.
The Award guarantees funding for 4 years, after which 3 additional years may be awarded pending receipt and approval of additional information. Investigators are nominated by either NINDS staff or members of the National Advisory Neurological Disorders and Stroke Council, from a pool of competing applicants during a grants cycle. The Council must approve each recommendation, with final selection being made by the NINDS Director.
Michael D. Cahalan, Ph.D., Professor
of Physiology and Biophysics, University of California, Irvine.
An immunologist, Dr. Cahalan is deeply interested in how T lymphocytes (white
blood cells that help the body fight off infection) function at the molecular
and cellular levels. He is also interested in diseases such as multiple
sclerosis, which are thought to have an immune component. T lymphocytes possess
numerous ion channels, which are intimately involved in the immune response and
offer promising targets for development of immune system therapeutic agents. His
Javits award will allow him to study the role calcium release-activated calcium
channels play in T cell responses, as well as to identify the molecular basis
for channel gating and the corresponding cellular response in immune system
activity.
Dr. K. George Chandy was awarded three teaching awards in 2004-05:
· Kaiser Permanente Teaching Award
· Silver Beaker Award
· Excellence in Teaching – Physiology
Dr. Janos Lanyi was awarded the MERIT Award extension by the National Advisory General medical Sciences Council in 2005 for his project “Light-Driven Ion Transport in Bacterial Rhodopsins”. Dr. Lanyi will receive an additional five years of support without having to submit a competing application.
Dr. Jay Gargus was nominated by the University of Hawaii for a nationally-competitive Federation of American Societies for Experimental Biology (FASEB) Visiting Professor award, which he received, allowing him to lecture and mentor junior faculty at the University of Hawaii.
Dr. Kenneth Baldwin was awarded the NASA Public Service Medal Award for Advisory Committee Service in 2005. This is the second NASA service medal that Dr. Baldwin has received. The first was awarded in 1999 for his accomplishments in space research.
2005 Physiology and
Biophysics Retreat
The Department held its research retreat at the UCLA Conference Center at
Lake Arrowhead on October 2, 3, and 4. The event features scientific
presentations by faculty members and a poster session in which graduate students
and postdoctoral fellows report their latest findings. The "Outstanding Poster
Award" this year was shared by Christine Beeton (Chandy Lab), Melanie Matheu (Cahalan
Lab), Sindy Wei (Cahalan Lab), and Shenyuan Zhang (Cahalan Lab).
NOBEL Prize awarded to Dr.
Irwin A. Rose, Department of Physiology & Biophysics